Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial
The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
The programme evaluated anselamimab as a first-line add-on to standard plasma cell dyscrasia therapy in patients with advanced cardiac AL amyloidosis
The filing is backed by results from the pivotal SERENA-6 Phase III trial
First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
Solvay will fund Pantys-led initiatives targeting vulnerable communities through product donations and menstrual health education programs
The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
Subscribe To Our Newsletter & Stay Updated